FDA ruling allows abortion drugs to be prescribed online and mailed

U.S. Food and Drug Administration Acting Commissioner’s decision to suspend enforcement of agency’s in-person prescription requirement for abortive drug puts women’s health and possibly lives at risk , pro-life leaders said.

PERSPECTIVE HEIGHTS – The Food and Drug Administration’s (FDA) decision to lift restrictions on the abortion pill mifepristone – paving the way for women to get the pill in the mail and abort themselves as early as 10 weeks gestation without an in-person clinic visit – sparked further criticism from life advocates.

The agency’s decision allows doctors to prescribe mifepristone online and send the pills to patients, eliminating the requirement that, for safety reasons, women physically receive the drug from their prescriber.

“One of the essential tasks of governments is to protect the health and well-being of citizens,” said the chairman of the Committee on Pro-Life Activities of the United States Conference of Catholic Bishops. Archbishop William E. Lori said in a statement. “As such, the FDA should act to protect the lives and health of mothers and children, rather than simply succumb to pressure from the abortion industry to relax safety standards.”

The FDA eliminated the in-person dispensing requirement in the Risk Mitigation Strategy (REMS), on Thursday, December 16. According to its website, the agency determined the data supported its decision to reverse the requirement for in-person dispensing of mifepristone, known as Mifeprex, to “reduce the burden on patient access.” and “to ensure that the benefits of the product outweigh the risks”.

Abortion advocates have pointed to abortion alternatives as a workaround or back-up plan for women to access abortion, while states restrict abortion and the Supreme Court of United States plans to challenge Roe v. Wade in the case of a Mississippi law that bans most abortions after 15 weeks of pregnancy.

However, pro-life groups have pointed out that this type of abortion – via Mifeprex – is not safe for women.

A box of the drug RU-486, an abortion pill known generically as mifepristone and under its brand name Mifeprex, is seen in an undated photo. (Photo: CNS/Danco Laboratories handout via Reuters)

In April, during the FDA’s initial announcement, Dr. Christina Francis, president of the American Association of Obstetricians/Gynecologists pro-life, said the lifting of safety restrictions is making women health pawns to to push for more abortions.

Francis said a recent adverse event analysis submitted to the FDA, with safety rules in place, “shows that more than 3,000 women are suffering from complications, of which 24 of these women died, and another 500 would have died if they had not reached the medical emergency room”. timely care.

Those numbers “will only increase” with the removal of current safety rules, she added.

“An in-person visit is a medically necessary and sound medical practice because it ensures that each woman receives a full assessment for any contraindications to medical abortion,” she added.

Back To Top